[ad_1]
Bengaluru:
Serum Institute of India mentioned on Friday it will obtain $150 million in funding from the Bill & Melinda Gates Foundation and the GAVI vaccines alliance to make 100 million COVID-19 vaccine doses for India and different rising economies as early as 2021.
The candidate vaccines, together with these from AstraZeneca and Novavax, can be priced at $three per dose and can be made out there in 92 nations in GAVI’s COVAX Advance Market Commitment (AMC), the corporate mentioned in a press release.
The Gates Foundation will present the funds to GAVI, which can be used to assist Serum Institute.
GAVI, backed by the Gates Foundation, is a public-private world well being partnership with the aim of accelerating entry to immunization in poor nations.
It co-leads COVAX – a scheme designed to ensure quick and equitable entry globally to COVID-19 vaccines – together with the World Health Organization and the Coalition for Epidemic Preparedness Innovations (CEPI).
COVAX goals to ship 2 billion doses of accredited and efficient COVID-19 vaccines by the tip of 2021.
India reported a file bounce in day by day coronavirus infections on Friday and have become the third nation on the earth to surpass 2 million instances. It lags solely the United States and Brazil within the variety of infections.
(Except for the headline, this story has not been edited by NDTV employees and is printed from a syndicated feed.)
[ad_2]
Source hyperlink